Samuel Agresta

2020

In 2020, Samuel Agresta earned a total compensation of $1.1M as Chief Medical Officer at Foghorn Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$99,573
Option Awards$542,224
Salary$412,000
Total$1,053,797

Agresta received $542.2K in option awards, accounting for 51% of the total pay in 2020.

Agresta also received $99.6K in non-equity incentive plan and $412K in salary.

Rankings

In 2020, Samuel Agresta's compensation ranked 8,403rd out of 13,090 executives tracked by ExecPay. In other words, Agresta earned more than 35.8% of executives.

ClassificationRankingPercentile
All
8,403
out of 13,090
36th
Division
Manufacturing
3,574
out of 5,618
36th
Major group
Chemicals And Allied Products
1,448
out of 2,251
36th
Industry group
Drugs
1,260
out of 1,951
35th
Industry
Pharmaceutical Preparations
930
out of 1,456
36th
Source: SEC filing on April 29, 2022.

Agresta's colleagues

We found two more compensation records of executives who worked with Samuel Agresta at Foghorn Therapeutics in 2020.

2020

Adrian Gottschalk

Foghorn Therapeutics

Chief Executive Officer

2020

Carl Decicco

Foghorn Therapeutics

Chief Scientific Officer

News

In-depth

You may also like